Hollatz competitive analysis

Latest publications and patents of Hollatz New

Explore the latest publications and patents granted to Hollatz, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Hollatz against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALSSep 11, 2020
Method For Producing A Freeze-Dried Pharmaceutical Composition Containing Mitomycin CMEDAC GESELLSCHAFT FR KLINISCHE SPEZIALPRPARATEAug 20, 2020
Process For The Preparation Of TravoprostCHINOIN GYGYSZER S VEGYSZETI TERMKEK GYRA ZRTOct 23, 2019
Method For Obtaining Elements Or Element Compounds From The Intermediate Products Or By-Products Obtained During The Production Of Titanium DioxideHUNTSMAN P&A UERDINGENJul 18, 2018

Latest PTAB cases involving Hollatz

Discover the latest PTAB cases involving Hollatz, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hollatz with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
HOLLATZ6 - - - Highly Aggressive
EUROAPI HUNGARY LIABILITY - 1 - - Non-Active
HUNTSMAN P&A UERDINGEN - 1 - - Non-Active
SALIX PHARMACEUTICALS - 17 - 3Non-Active